{"data":{"id":"10.6084/m9.figshare.1568337.v1","type":"dois","attributes":{"doi":"10.6084/m9.figshare.1568337.v1","prefix":"10.6084","suffix":"m9.figshare.1568337.v1","identifiers":[],"alternateIdentifiers":[],"creators":[{"name":"Ladoire, Sylvain","nameType":"Personal","givenName":"Sylvain","familyName":"Ladoire","affiliation":[],"nameIdentifiers":[]},{"name":"Penault-Llorca, Frédérique","nameType":"Personal","givenName":"Frédérique","familyName":"Penault-Llorca","affiliation":[],"nameIdentifiers":[]},{"name":"Senovilla, Laura","nameType":"Personal","givenName":"Laura","familyName":"Senovilla","affiliation":[],"nameIdentifiers":[]},{"name":"Dalban, Cécile","nameType":"Personal","givenName":"Cécile","familyName":"Dalban","affiliation":[],"nameIdentifiers":[]},{"name":"Enot, David","nameType":"Personal","givenName":"David","familyName":"Enot","affiliation":[],"nameIdentifiers":[]},{"name":"Locher, Clara","nameType":"Personal","givenName":"Clara","familyName":"Locher","affiliation":[],"nameIdentifiers":[]},{"name":"Prada, Nicole","nameType":"Personal","givenName":"Nicole","familyName":"Prada","affiliation":[],"nameIdentifiers":[]},{"name":"Vichnou Poirier-Colame","affiliation":[],"nameIdentifiers":[]},{"name":"Kariman Chaba","affiliation":[],"nameIdentifiers":[]},{"name":"Arnould, Laurent","nameType":"Personal","givenName":"Laurent","familyName":"Arnould","affiliation":[],"nameIdentifiers":[]},{"name":"Ghiringhelli, François","nameType":"Personal","givenName":"François","familyName":"Ghiringhelli","affiliation":[],"nameIdentifiers":[]},{"name":"Fumoleau, Pierre","nameType":"Personal","givenName":"Pierre","familyName":"Fumoleau","affiliation":[],"nameIdentifiers":[]},{"name":"Spielmann, Marc","nameType":"Personal","givenName":"Marc","familyName":"Spielmann","affiliation":[],"nameIdentifiers":[]},{"name":"Delaloge, Suzette","nameType":"Personal","givenName":"Suzette","familyName":"Delaloge","affiliation":[],"nameIdentifiers":[]},{"name":"Poillot, Marie Laure","nameType":"Personal","givenName":"Marie Laure","familyName":"Poillot","affiliation":[],"nameIdentifiers":[]},{"name":"Arveux, Patrick","nameType":"Personal","givenName":"Patrick","familyName":"Arveux","affiliation":[],"nameIdentifiers":[]},{"name":"Goubar, Aicha","nameType":"Personal","givenName":"Aicha","familyName":"Goubar","affiliation":[],"nameIdentifiers":[]},{"name":"Andre, Fabrice","nameType":"Personal","givenName":"Fabrice","familyName":"Andre","affiliation":[],"nameIdentifiers":[]},{"name":"Zitvogel, Laurence","nameType":"Personal","givenName":"Laurence","familyName":"Zitvogel","affiliation":[],"nameIdentifiers":[]},{"name":"Kroemer, Guido","nameType":"Personal","givenName":"Guido","familyName":"Kroemer","affiliation":[],"nameIdentifiers":[]}],"titles":[{"title":"Combined evaluation of lc3b puncta and hmgb1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer"}],"publisher":"Taylor \u0026 Francis","container":{},"publicationYear":2015,"subjects":[{"subject":"Hematology"},{"subject":"Cancer"},{"subject":"Biological Sciences"},{"subject":"Immunology"},{"subject":"FOS: Clinical medicine","schemeUri":"http://www.oecd.org/science/inno/38235147.pdf","subjectScheme":"Fields of Science and Technology (FOS)"},{"subject":"FOS: Clinical medicine","subjectScheme":"Fields of Science and Technology (FOS)"},{"subject":"Biotechnology"},{"subject":"Physiology"},{"subject":"FOS: Biological sciences","schemeUri":"http://www.oecd.org/science/inno/38235147.pdf","subjectScheme":"Fields of Science and Technology (FOS)"},{"subject":"FOS: Biological sciences","subjectScheme":"Fields of Science and Technology (FOS)"},{"subject":"Molecular Biology"},{"subject":"Cell Biology"},{"subject":"Medicine"}],"contributors":[],"dates":[{"date":"2015-10-03","dateType":"Created"},{"date":"2019-06-03","dateType":"Updated"},{"date":"2015","dateType":"Issued"}],"language":null,"types":{"ris":"DATA","bibtex":"misc","citeproc":"dataset","schemaOrg":"Dataset","resourceType":"Dataset","resourceTypeGeneral":"Dataset"},"relatedIdentifiers":[{"relationType":"IsSupplementTo","relatedIdentifier":"10.1080/15548627.2015.1082022","relatedIdentifierType":"DOI"},{"relationType":"IsPreviousVersionOf","relatedIdentifier":"10.6084/m9.figshare.1568337","relatedIdentifierType":"DOI"}],"relatedItems":[],"sizes":["5383611 Bytes"],"formats":[],"version":null,"rightsList":[{"rights":"Creative Commons Attribution 4.0 International","rightsUri":"https://creativecommons.org/licenses/by/4.0/legalcode","schemeUri":"https://spdx.org/licenses/","rightsIdentifier":"cc-by-4.0","rightsIdentifierScheme":"SPDX"}],"descriptions":[{"description":"ABSTRACTIn spite of adjuvant chemotherapy, a significant fraction of patients with localized breast cancer (BC) relapse after optimal treatment. We determined the occurrence of cytoplasmic MAP1LC3B/LC3B (microtubule-associated protein 1 light chain 3B)-positive puncta, as well as the presence of nuclear HMGB1 (high mobility group box 1) in cancer cells within surgical BC specimens by immunohistochemistry, first in a test cohort (152 patients) and then in a validation cohort of localized BC patients who all received adjuvant anthracycline-based chemotherapy (1646 patients). Cytoplasmic LC3B\u003csup\u003e+\u003c/sup\u003e puncta inversely correlated with the intensity of SQSTM1 staining, suggesting that a high percentage cells with LC3B\u003csup\u003e+\u003c/sup\u003e puncta reflects autophagic flux. After setting optimal thresholds in the test cohort, cytoplasmic LC3B\u003csup\u003e+\u003c/sup\u003e puncta and nuclear HMGB1 were scored as positive in 27.2% and 28.6% of the tumors, respectively, in the validation cohort, while 8.7% were considered as double positive. LC3B\u003csup\u003e+\u003c/sup\u003e puncta or HMGB1 expression alone did not constitute independent prognostic factors for metastasis-free survival (MFS) in multivariate analyses. However, the combined positivity for LC3B\u003csup\u003e+\u003c/sup\u003e puncta and nuclear HMGB1 constituted an independent prognostic factor significantly associated with prolonged MFS (hazard ratio: 0.49 95% confidence interval [0.26-0.89]; \u003ci\u003eP\u003c/i\u003e=0.02), and improved breast cancer specific survival (hazard ratio: 0.21 95% confidence interval [0.05-0.85]; \u003ci\u003eP\u003c/i\u003e=0.029). Subgroup analyses revealed that within patients with poor-prognosis BC, HMGB1\u003csup\u003e+ \u003c/sup\u003eLC3B\u003csup\u003e+\u003c/sup\u003e double-positive tumors had a better prognosis than BC that lacked one or both of these markers. Altogether, these results suggest that the combined positivity for LC3B\u003csup\u003e+\u003c/sup\u003e puncta and nuclear HMGB1 is a positive predictor for longer BC survival.","descriptionType":"Abstract"}],"geoLocations":[],"fundingReferences":[],"xml":"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","url":"https://tandf.figshare.com/articles/dataset/Combined_evaluation_of_lc3b_puncta_and_hmgb1_expression_predicts_residual_risk_of_relapse_after_adjuvant_chemotherapy_in_breast_cancer/1568337/1","contentUrl":null,"metadataVersion":3,"schemaVersion":"http://datacite.org/schema/kernel-4","source":"mds","isActive":true,"state":"findable","reason":null,"viewCount":0,"viewsOverTime":[],"downloadCount":0,"downloadsOverTime":[],"referenceCount":0,"citationCount":0,"citationsOverTime":[],"partCount":0,"partOfCount":0,"versionCount":0,"versionOfCount":0,"created":"2016-01-20T06:32:03.000Z","registered":"2016-01-20T06:32:04.000Z","published":"2015","updated":"2020-09-04T15:26:11.000Z"},"relationships":{"client":{"data":{"id":"figshare.ars","type":"clients"}},"provider":{"data":{"id":"otjm","type":"providers"}},"media":{"data":{"id":"10.6084/m9.figshare.1568337.v1","type":"media"}},"references":{"data":[]},"citations":{"data":[]},"parts":{"data":[]},"partOf":{"data":[]},"versions":{"data":[]},"versionOf":{"data":[]}}}}